Lupin 2024

bioequivalent of Focalin XR

Teva ships Focalin XR generic

Teva ships Focalin XR generic

NORTH WALES, Pa. – Teva Pharmaceuticals has released dexmethylphenidate hydrochloride extended-release capsules (CII), a medication for attention deficit hyperactivity disorder (ADHD), in a 20-mg strength. Teva said Monday that its product is AB-rated and is a bioequivalent of Focalin XR extended-release capsules (CII) from Novartis. With the addition of the new strength, Teva now offers

PP_1170x120_10-25-21